[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Contents of Prescrire International April 2002
- From: Prescrire International <international@prescrire.org>
- Date: Thu, 11 Apr 2002 09:40:03 -0400 (EDT)
E-drug: Contents of Prescrire International April 2002
-------------------------------------------------------------------------
Prescrire International is the English language edition of la revue
Prescrire. It contains comprehensive evaluations of new drugs and
new indication, and reviews of adverse effects and therapeutic
interventions. Prescrire International is published six times a year.
Solidarity Subscription Rates are available for health professionals
working in low income countries. The Solidarity Rates apply to all
subscribers who live in low income countries, excluding
pharmaceutical companies.
Contents of Prescrire International
April 2002
EDITORIAL
The real beneficiaries of European drug policy
NEW PRODUCTS
Meningococcal vaccine against serogroups A, C, Y and W-135
(new preparation)
Offers an advantage against A, C, Y and W-135 meningococcal
infection
Epoetin alfa and epoetin beta (new indications)
For anaemia following cytotoxic chemotherapy
Capecitabine and tegafur + uracil (new preparations)
No major breakthrough for colorectal cancer
Gabapentin (new indication)
No advance in add-on therapy of partial epilepsy in children
ADVERSE EFFECTS
Electrolyte disorders and sodium phosphates
Nitrofurantoin and neuropathy
Erythroblastopenia with epoetin
Convulsions and hypersensitivity due to bupropion
Urinary retention with loperamide
Failure of ceramic femoral heads
REVIEWS
2001 Prescrire Awards
Drugs in 2001
Type 1 diabetes: benefits of intensive insulin therapy
SHORTCUTS
Racecadotril - Ganirelix - Azithromycin - Iloprost - Single-dose
fluconazole
__________________________________________________________
Prescrire International is financed by subscription fees only. We
cannot provide free subscriptions. Send us your name and address
if you want to receive a sample issue.
An annual subscription covers six issues and a five-year index.
Standard Subscription Rates:
Individuals 85 USD (FF 600 or 91. 47 Euro)
students 45 USD (FF 300 or 45. 73 Euro)
Commercial institutions 210 USD (FF 1500 or 228. 67 Euro)
Solidarity Subscription Rates countries with GNP < 10,000 USD*:
Individuals 35 USD (FF 250 or 38.11 Euro)
Students 21 USD (FF 150 or 27. 87 Euro)
Institutions 85 USD (FF 600 or 91. 47 Euro) (pharmaceutical
companies excepted)
*The following countries are not eligible for Solidarity Subscription
Rates: Australia, Austria, the Bahamas, Belgium, Brunei, Canada,
Cyprus, Denmark, Finland, France, Germany, Greece, Hong Kong,
Iceland, Ireland, Israel, Italy, Japan, Kuwait, Liechtenstein,
Luxembourg, Monaco, the Netherlands, New Zealand, Norway,
Portugal, Qatar, Singapore, Spain, Sweden, Switzerland, United
Kingdom, United Arab Emirates, United States of America.
Prescrire International
BP 459
75527 Paris Cedex 11
Tel: 33 1 49 23 72 65
Fax: 33 1 48 07 87 32
E-mail: International@prescrire.org
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html
|